Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting.
Cataldo PatrunoGiuseppe LaulettaElena PezzoloValeria BoccalettiMariateresa RossiFrancesca CaroppoAnna Belloni FortinaFilomena RussoBarbara CocurocciaGiacomo Dal BelloFabrizio MartoraFrancesca di VicoMaddalena NapolitanoPublished in: Clinical drug investigation (2024)
Our real-world experience seems to confirm the efficacy and safety of upadacitinib for the long-term treatment of moderate-to-severe AD in adolescents.